<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To study effects of the disease activity and comorbid <z:hpo ids='HP_0011010'>chronic</z:hpo> conditions on the incidence of <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental disorders</z:e> in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) treated in the State Institute of Rheumatology, RAMS </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: A total of 115 patients with documented SLE (age 24-45 years, median 34 years, SLE duration 4-17, median 8 years) participated in the study </plain></SENT>
<SENT sid="2" pm="."><plain>SLE activity was evaluated by SLEDAI scale, <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>--by ultrasonic arterial dopplerography, <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental disorders</z:e>--by psychological and psychic scales according to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IDC</z:e>-10 </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">Mental disorders</z:e> were detected in 76 of 115 (66%) patients: <z:hpo ids='HP_0000739'>anxiety</z:hpo> and <z:hpo ids='HP_0000716'>depression</z:hpo> (83%), <z:hpo ids='HP_0000716'>depression</z:hpo> episodes (40%), maladaptation (24%), generalized <z:hpo ids='HP_0000739'>anxiety</z:hpo> (10%), <z:e sem="disease" ids="C0013415" disease_type="Mental or Behavioral Dysfunction" abbrv="">dysthymia</z:e> (9%) </plain></SENT>
<SENT sid="4" pm="."><plain>Manifest <z:e sem="disease" ids="C0009241" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive disorders</z:e> were seen in 7% of examinees </plain></SENT>
<SENT sid="5" pm="."><plain>SLE patients with and without <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental disorders</z:e> did not differ by age, gender, SLE duration and activity, cumulative doses of <z:chebi fb="1" ids="24261">glucocorticoids</z:chebi> and cytotoxic drugs, but differed by diagnosed <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (23 and 8%, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> SLE patients with the history of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> had <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental disorders</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>SLE patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> had <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental disorders</z:e> in 85%, while controls--in 49% </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">Mental disorders</z:e> are found frequently in SLE patients (66%) </plain></SENT>
<SENT sid="9" pm="."><plain>83% of these disorders are anxiodepressive </plain></SENT>
<SENT sid="10" pm="."><plain>Incidence of <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">mental disorders</z:e> in SLE patients do not correlate with age, gender, SLE duration and activity, doses of <z:chebi fb="1" ids="24261">glucocorticoids</z:chebi> and cytotoxic drugs, but correlate with comorbid diseases (<z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0011009'>acute</z:hpo> cerebral attacks, <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjogren's syndrome</z:e> </plain></SENT>
</text></document>